Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for Neuroenhancement in Acute Patients
NCT05479032Phase 2Recruiting
- Sponsor
- University Hospital Tübingen
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amantadine in disorder of consciousness (DOC), sponsored by University Hospital Tübingen. Started Mar 2023; status: recruiting.
02
Drugs
amantadine
03
Conditions
disorder of consciousness (DOC)
Beyond the preview
Go deeper on NCT05479032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05479032.